Oloa
-
High Purity Peptides Retatrutide 10mg mo le Pa'u Ma'i Ma'isuka
Mama: >99%
Setete: Lyophilized Powder
Fa'aaliga: Pa'epa'e pa'epa'e
Fa'amatalaga: 5mg/10mg/15mg/20mg/30mg
-
Retatrutide
Retaglutide o se dipeptidyl peptidase-4 (DPP-4) inhibitor vasega hypoglycemic vailaʻau fou e mafai ona puipuia le faʻaleagaina o le glucagon-like peptide-1 (GLP-1) ma le glucose-dependent insulin-releasing polypeptide (GIP) e le DPP-4 enzyme i totonu o le inumaga ma le toto, faʻaumiumi a latou gaioiga, e aunoa ma le faʻamalosia o le faʻaogaina o le inisalini faʻasaʻo, e aunoa ma le faʻamalosia o le faʻaogaina o le inisalini e ala i le faʻaogaina o le inisalini. fa'aitiitia le fa'aliloina o le glucagon e sela pancreatic α, ma sili atu ai le pulea lelei o le suka toto pe a mae'a. E fa'atino lelei i tulaga o le a'afiaga o le hypoglycemic, fa'apalepale, ma le tausisia.
-
Inlisiran sodium
Inclisiran sodium API (Active Pharmaceutical Ingredient) o loʻo suʻesuʻeina muamua i le tulaga o le RNA interference (RNAi) ma le cardiovascular therapeutics. I le avea ai o se siRNA fa'aluaina e fa'atatau i le PCSK9 gene, o lo'o fa'aaogaina i su'esu'ega fa'apitoa ma su'esu'ega fa'afoma'i e iloilo ai ta'iala mo le fa'aitiitia o le LDL-C (low-density lipoprotein cholesterol). E avea foi ma se faʻataʻitaʻiga faʻataʻitaʻiga mo le suʻesuʻeina o faiga faʻapipiʻi siRNA, faʻamautu, ma faʻamaʻi RNA faʻatatau ile ate.
-
Fmoc-Gly-Gly-OH
Fmoc-Gly-Gly-OH o se dipeptide faʻaaogaina e fai ma poloka fau fale i le faʻapipiʻiina o le peptide solid-phase (SPPS). O loʻo faʻaalia ai toega glycine e lua ma se N-terminus puipuia Fmoc, faʻatagaina mo le faʻalauteleina o filifili peptide. Ona o le laʻititi o le glycine ma le fetuutuunaʻi, o lenei dipeptide e masani ona suʻesuʻeina i le tulaga o le peptide backbone dynamics, fesoʻotaʻiga mamanu, ma faʻataʻitaʻiga faʻatulagaina i peptides ma polotini.
-
Fmoc-Thr(tBu)-Phe-OH
Fmoc-Thr(tBu)-Phe-OH o se poloka fale dipeptide e masani ona faʻaaogaina i le faʻaogaina o le peptide solid-phase (SPPS). O le vaega Fmoc (9-fluorenylmethyloxycarbonyl) e puipuia le N-terminus, ae o le tBu (tert-butyl) vaega e puipuia le filifili hydroxyl o le threonine. O lenei dipeptide puipuia o loʻo suʻesuʻeina mo lana matafaioi i le faʻafaigofieina o le peptide elongation lelei, faʻaitiitia le racemization, ma le faʻataʻitaʻiina o faʻasologa faʻasologa faʻasologa i le fausaga o porotini ma suʻesuʻega fegalegaleaiga.
-
AEEA-AEEA
AEEA-AEEA o se hydrophilic, fetuutuunai spacer e masani ona faʻaaogaina i le peptide ma suʻesuʻega faʻasaina. E aofia ai vaega e lua e fa'avae i le ethylene glycol, e fa'aaogaina mo le su'esu'eina o a'afiaga o le umi o feso'ota'iga ma le fetuutuuna'i i fegalegaleaiga mole, solubility, ma gaioiga fa'aola. E masani ona fa'aogaina e le au su'esu'e ia iunite AEEA e iloilo ai pe fa'afefea ona fa'aaafia e tagata va'ava'ai le fa'atinoga o fa'aputuga o vaila'au fa'ama'i (ADCs), fa'atasiga peptide-drug, ma isi bioconjugates.
-
Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH
O lenei tuufaatasiga o se puipuiga, faʻaogaina lysine derivative faʻaaogaina i le peptide synthesis ma le atinaʻeina o vailaʻau. O loʻo faʻaalia ai se vaega Fmoc mo le puipuiga o le N-terminal, ma se suiga i le itu-chain ma Eic(OtBu) (eicosanoic acid derivative), γ-glutamic acid (γ-Glu), ma le AEEA (aminoethoxyethoxyacetate). O nei vaega ua mamanuina e suʻesuʻe ai aʻafiaga o le lipidation, kemisi spacer, ma le faʻasaʻoina o fualaau faasaina. O lo'o su'esu'eina lautele i le tulaga o ta'iala fa'ata'ita'i, feso'ota'iga ADC, ma peptide e feso'ota'i ma membrane.
-
Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH
O lenei fa'aputu o se fa'aliliuga o le lysine ua fa'aogaina i le peptide synthesis, aemaise lava mo le fausiaina o peptide conjugates taula'i po'o multifunctional. O le vaega Fmoc e fa'atagaina le fa'asologa fa'asolosolo e ala ile Fmoc solid-phase peptide synthesis (SPPS). O le filifili o le itu e suia i le stearic acid derivative (Ste), γ-glutamic acid (γ-Glu), ma le lua AEEA (aminoethoxyethoxyacetate) soʻotaga, lea e maua ai le hydrophobicity, meatotino tau, ma fetuutuunai avanoa. E masani ona suʻesuʻeina mo lana matafaioi i le tuʻuina atu o vailaʻau, e aofia ai le antibody-drug conjugates (ADCs) ma le peptides e tuʻuina i totonu.
-
Liraglutide Anti-Diabetics mo le Pulea o le Suka toto CAS NO.204656-20-2
Mea gaogao:Liraglutide (analog of human glucagon-like peptide-1 (GLP-1) gaosia e le fefete e ala i le genetic recombination technology).
Igoa vaila'au:Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
Isi mea'ai:Disodium Hydrogen Phosphate Dihydrate, Propylene Glycol, Hydrochloric Acid ma/po'o le Sodium Hydroxide (e na'o Fa'atonu pH), Phenol, ma Suavai mo tui.
-
Leuprorelin Acetate faʻatonutonuina le faʻaogaina o Hormones Gonadal
Igoa: Leuprorelin
Numera CAS: 53714-56-0
fua mole: C59H84N16O12
mamafa mole: 1209.4
Numera EINECS: 633-395-9
Ta'amilosaga fa'apitoa: D25 -31.7° (c = 1 i le 1% acetic acid)
Malosi: 1.44±0.1 g/cm3(Va'ai)
-
Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH
Boc-His(Trt)-Aib-Gln(Trt)-Gly-OHo se tetrapeptide puipuia o loʻo faʻaaogaina i le peptide synthesis ma suʻesuʻega faʻavae. O le vaega o le Boc (tert-butyloxycarbonyl) e puipuia le N-terminus, ae o vaega o le Trt (trityl) e puipuia ai filifili itu o le histidine ma le glutamine e puipuia ai gaioiga e le manaʻomia. O le i ai o le Aib (α-aminoisobutyric acid) e faʻaleleia ai le faʻaogaina o le helical ma faʻaleleia le mautu o le peptide. O lenei peptide e taua tele mo le suʻesuʻeina o le gaugau peptide, faʻamautu, ma o se faʻailoga mo le mamanuina o peptides olaola.
-
BPC-157
BPC-157 API fa'aaogaina le fa'agasologa o vaega mautu (SPPS):
maualuga mama: ≥99% (su'esu'eina HPLC)
Le maualalo o mea leaga o totoe, leai se endotoxin, leai se fa'aleaga uamea mamafa
Tulaga mautu, malosi toe fai, lagolago tulaga tui le faaaogaina
Lagolago le sapalai o le kalama ma le kilokalama e fa'amalieina mana'oga o la'asaga eseese mai le su'esu'ega ma le fa'atauga.
